Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.

Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, Dorbin CD, Qiu D, Hu WT.

Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.

2.

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort.

St John-Williams L, Blach C, Toledo JB, Rotroff DM, Kim S, Klavins K, Baillie R, Han X, Mahmoudiandehkordi S, Jack J, Massaro TJ, Lucas JE, Louie G, Motsinger-Reif AA, Risacher SL; Alzheimer’s Disease Neuroimaging Initiative; Alzheimer’s Disease Metabolomics Consortium, Saykin AJ, Kastenmüller G, Arnold M, Koal T, Moseley MA, Mangravite LM, Peters MA, Tenenbaum JD, Thompson JW, Kaddurah-Daouk R.

Sci Data. 2017 Oct 17;4:170140. doi: 10.1038/sdata.2017.140.

3.

Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume.

Caldwell JZK, Berg JL, Cummings JL, Banks SJ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2017 Sep 12;9(1):72. doi: 10.1186/s13195-017-0300-8.

4.

Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.

Falahati F, Ferreira D, Muehlboeck JS, Eriksdotter M, Simmons A, Wahlund LO, Westman E.

Neuroimage Clin. 2017 Aug 14;16:418-428. doi: 10.1016/j.nicl.2017.08.014. eCollection 2017.

5.

Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.

Dufouil C, Dubois B, Vellas B, Pasquier F, Blanc F, Hugon J, Hanon O, Dartigues JF, Harston S, Gabelle A, Ceccaldi M, Beauchet O, Krolak-Salmon P, David R, Rouaud O, Godefroy O, Belin C, Rouch I, Auguste N, Wallon D, Benetos A, Pariente J, Paccalin M, Moreaud O, Hommet C, Sellal F, Boutoleau-Bretonniére C, Jalenques I, Gentric A, Vandel P, Azouani C, Fillon L, Fischer C, Savarieau H, Operto G, Bertin H, Chupin M, Bouteloup V, Habert MO, Mangin JF, Chêne G; MEMENTO cohort Study Group.

Alzheimers Res Ther. 2017 Aug 29;9(1):67. doi: 10.1186/s13195-017-0288-0.

6.

APOE genotype and early β-amyloid accumulation in older adults without dementia.

Lim YY, Mormino EC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Sep 5;89(10):1028-1034. doi: 10.1212/WNL.0000000000004336. Epub 2017 Aug 9.

PMID:
28794245
7.

Cross-validation of optimized composites for preclinical Alzheimer's disease.

Donohue MC, Sun CK, Raman R, Insel PS, Aisen PS; AN-ADNI; AIBL; J-ADNI.

Alzheimers Dement (N Y). 2017 Jan;3(1):123-129. doi: 10.1016/j.trci.2016.12.001.

PMID:
28758145
8.

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.

Yang SY, Chiu MJ, Chen TF, Horng HE.

Neurol Ther. 2017 Jul;6(Suppl 1):37-56. doi: 10.1007/s40120-017-0075-7. Epub 2017 Jul 21. Review.

9.

Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.

Bilgel M, Koscik RL, An Y, Prince JL, Resnick SM, Johnson SC, Jedynak BM.

J Alzheimers Dis. 2017;59(4):1335-1347. doi: 10.3233/JAD-170448.

10.

Obesity and Co-morbid Conditions Are Associated with Specific Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Sanderlin AH, Todem D, Bozoki AC.

Front Aging Neurosci. 2017 May 29;9:164. doi: 10.3389/fnagi.2017.00164. eCollection 2017. Erratum in: Front Aging Neurosci. 2017 Oct 09;9:325.

11.

Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis.

Eppig JS, Edmonds EC, Campbell L, Sanderson-Cimino M, Delano-Wood L, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2017 Aug;23(7):564-576. doi: 10.1017/S135561771700039X. Epub 2017 Jun 5.

12.

Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment.

Thomas KR, Edmonds EC, Delano-Wood L, Bondi MW.

J Int Neuropsychol Soc. 2017 Jul;23(6):521-527. doi: 10.1017/S1355617717000285. Epub 2017 May 10.

13.

Memory is preserved in older adults taking AT1 receptor blockers.

Ho JK, Nation DA; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2017 Apr 26;9(1):33. doi: 10.1186/s13195-017-0255-9.

14.

Increased Diagnostic Accuracy of Digital vs. Conventional Clock Drawing Test for Discrimination of Patients in the Early Course of Alzheimer's Disease from Cognitively Healthy Individuals.

Müller S, Preische O, Heymann P, Elbing U, Laske C.

Front Aging Neurosci. 2017 Apr 11;9:101. doi: 10.3389/fnagi.2017.00101. eCollection 2017.

15.

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.

Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z.

16.

Adding Recognition Discriminability Index to the Delayed Recall Is Useful to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.

Russo MJ, Campos J, Vázquez S, Sevlever G, Allegri RF; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 Mar 10;9:46. doi: 10.3389/fnagi.2017.00046. eCollection 2017.

17.

Age at injury is associated with the long-term cognitive outcome of traumatic brain injuries.

Li W, Risacher SL, McAllister TW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement (Amst). 2017 Mar 2;6:196-200. doi: 10.1016/j.dadm.2017.01.008. eCollection 2017.

18.

Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.

Son SJ, Kim J, Park H.

PLoS One. 2017 Mar 23;12(3):e0173426. doi: 10.1371/journal.pone.0173426. eCollection 2017.

19.

Genetic epistasis regulates amyloid deposition in resilient aging.

Felsky D, Xu J, Chibnik LB, Schneider JA, Knight J, Kennedy JL; Alzheimer's Disease Neuroimaging Initiative, Bennett DA, De Jager PL, Voineskos AN.

Alzheimers Dement. 2017 Oct;13(10):1107-1116. doi: 10.1016/j.jalz.2017.01.027. Epub 2017 Mar 17.

PMID:
28322202
20.

Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns.

Park JY, Na HK, Kim S, Kim H, Kim HJ, Seo SW, Na DL, Han CE, Seong JK; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2017 Mar 9;7:43270. doi: 10.1038/srep43270.

Supplemental Content

Support Center